Next Article in Journal
A New Isoflavonoid from Seeds of Lepidium sativum L. and Its Protective Effect on Hepatotoxicity Induced by Paracetamol in Male Rats
Next Article in Special Issue
Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I
Previous Article in Journal
Editorial to the Organophosphorus Chemistry Special Issue of Molecules (2012–2014)
Previous Article in Special Issue
Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists
Due to scheduled maintenance work on our core network, there may be short service disruptions on this website between 16:00 and 16:30 CEST on September 25th.
Article

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II

1
Normandie Univ, Laboratoire C.O.B.R.A., UMR 6014 and FR 3038; Univ Rouen; INSA de Rouen; CNRS, Bâtiment I.R.C.O.F. rue Tesnière, Mont-Saint-Aignan F-76821, France
2
Diaxonhit, 65 boulevard Masséna, Paris F-75013, France
*
Author to whom correspondence should be addressed.
Received: 7 August 2014 / Revised: 15 September 2014 / Accepted: 16 September 2014 / Published: 26 September 2014
(This article belongs to the Special Issue Design and Study of Kinase Inhibitors)
The convenient synthesis of a focused library (forty molecules) of novel 6,6,5-tricyclic thiazolo[5,4-f]quinazolines was realized mainly under microwave irradiation. A novel 6-aminobenzo[d]thiazole-2,7-dicarbonitrile (1) was used as a versatile molecular platform for the synthesis of various derivatives. Kinase inhibition, of the obtained final compounds, was evaluated on a panel of two kinases (DYRK1A/1B) together with some known reference DYRK1A and DYRK1B inhibitors (harmine, TG003, NCGC-00189310 and leucettine L41). Compound IC50 values were obtained and compared. Five of the novel thiazolo[5,4-f]quinazoline derivatives prepared, EHT 5372 (8c), EHT 6840 (8h), EHT 1610 (8i), EHT 9851 (8k) and EHT 3356 (9b) displayed single-digit nanomolar or subnanomolar IC50 values and are among the most potent DYRK1A/1B inhibitors disclosed to date. DYRK1A/1B kinases are known to be involved in the regulation of various molecular pathways associated with oncology, neurodegenerative diseases (such as Alzheimer disease, AD, or other tauopathies), genetic diseases (such as Down Syndrome, DS), as well as diseases involved in abnormal pre-mRNA splicing. The compounds described in this communication constitute a highly potent set of novel molecular probes to evaluate the biology/pharmacology of DYR1A/1B in such diseases. View Full-Text
Keywords: thiazolo[5,4-f]quinazolines; kinase inhibitors; DYRK1A; DYRK1B; microwave-assisted chemistry; Dimroth rearrangement; EHT 5372; EHT 6840; EHT 1610; EHT 9851; EHT 3356 thiazolo[5,4-f]quinazolines; kinase inhibitors; DYRK1A; DYRK1B; microwave-assisted chemistry; Dimroth rearrangement; EHT 5372; EHT 6840; EHT 1610; EHT 9851; EHT 3356
Show Figures

Graphical abstract

MDPI and ACS Style

Foucourt, A.; Hédou, D.; Dubouilh-Benard, C.; Girard, A.; Taverne, T.; Casagrande, A.-S.; Désiré, L.; Leblond, B.; Besson, T. Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II. Molecules 2014, 19, 15411-15439. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules191015411

AMA Style

Foucourt A, Hédou D, Dubouilh-Benard C, Girard A, Taverne T, Casagrande A-S, Désiré L, Leblond B, Besson T. Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II. Molecules. 2014; 19(10):15411-15439. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules191015411

Chicago/Turabian Style

Foucourt, Alicia, Damien Hédou, Carole Dubouilh-Benard, Angélique Girard, Thierry Taverne, Anne-Sophie Casagrande, Laurent Désiré, Bertrand Leblond, and Thierry Besson. 2014. "Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II" Molecules 19, no. 10: 15411-15439. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules191015411

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop